Mutations affecting beta-tubulin folding and degradation

Yaqing Wang1, Guoling Tian2, Nicholas J Cowan2

  • 1Department of Integrative Biology and Pharmacology, The University of Texas Medical School, Houston, Texas 77030.

Insights

Scientists identified mutations that destabilize mutant beta-tubulin, preventing microtubule incorporation. This leads to proteasomal degradation and reduced cellular tubulin without affecting cell growth.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Protein Folding and Degradation

Background:

  • Beta-tubulin is a critical component of microtubules, essential for cell structure and division.
  • Mutations in beta-tubulin can lead to altered protein stability and function.
  • Cellular mechanisms, including chaperones and proteasomes, regulate protein folding and degradation.

Purpose of the Study:

  • To identify cis-acting mutations that destabilize a colcemid-resistant mutant beta-tubulin (D45Y).
  • To investigate the folding, assembly, and degradation pathways of these destabilized mutant beta-tubulins.
  • To understand the cellular consequences of reduced beta-tubulin levels due to mutant protein instability.

Main Methods:

  • Analysis of revertants from a colcemid-resistant Chinese hamster ovary cell line.
  • Identification of cis-acting mutations affecting mutant beta-tubulin stability.
  • In vivo and in vitro assays to assess tubulin folding, heterodimerization, and proteasomal degradation (using MG132).
  • Measurement of cellular tubulin content and assessment of cell growth and survival.

Main Results:

  • Four cis-acting mutations (L187R, Y398C, deletion, truncation) were identified that destabilize mutant beta-tubulin.
  • Destabilized beta-tubulins fail to form heterodimers, associate with chaperonin CCT, and do not interact with folding cofactors.
  • Improperly folded beta-tubulin is degraded by the proteasome, leading to a 30-40% decrease in total cellular tubulin.
  • Reduced tubulin content does not impact cell growth or survival.

Conclusions:

  • Specific mutations can render mutant beta-tubulin unstable, leading to its failure in productive folding and microtubule incorporation.
  • The proteasome efficiently degrades misfolded beta-tubulin, preventing its accumulation.
  • Cells can tolerate significant reductions in beta-tubulin levels without compromising viability or growth, suggesting robust cellular regulation.

Related Concept Videos

Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
Microtubule Instability02:17

Microtubule Instability

Microtubules are hollow cylindrical filaments having a diameter of approximately 25 nm and a length that varies from 200 nm to 25 μm. GTP-bound tubulin subunits form αβ-heterodimers for microtubule assembly. These core building blocks interact longitudinally, polymerizing into protofilaments. The protofilaments then interact with one another through lateral bonding forces to form stable cylindrical microtubules. These cylindrical filaments are dynamic as they undergo repeated assembly and...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...